Tanigawa, K., & Redmond, W. L. Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationTanigawa, Kengo, and William L. Redmond. Current Landscape and Future Prospects of Interleukin-2 Receptor (IL-2R) Agonists in Cancer Immunotherapy. Taylor & Francis Group.
MLA (9th ed.) CitationTanigawa, Kengo, and William L. Redmond. Current Landscape and Future Prospects of Interleukin-2 Receptor (IL-2R) Agonists in Cancer Immunotherapy. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.